Amundi
KZR

Amundi’s Kezar Life Sciences KZR Stock Holding History

Amundi’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,224
Closed -$54.1K – 2219
2024
Q4 		$54.1K Hold
8,224
– – ﹤0.01% 1841
2024
Q3 		$60.9K Hold
8,224
– – ﹤0.01% 1825
2024
Q2 		$47.6K Hold
8,224
– – ﹤0.01% 1796
2024
Q1 		$64.8K Hold
8,224
– – ﹤0.01% 1821
2023
Q4 		$74.8K Buy
+8,224
New +$72.3K ﹤0.01% 1829
2023
Q2 		– Sell
-523
Closed -$12.3K – 2085
2023
Q1 		$12.3K Hold
523
– – ﹤0.01% 1995
2022
Q4 		$32.1K Buy
+523
New +$38.8K ﹤0.01% 1755

Other funds holding KZR

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Amundi's KZR Position: Q1 2025 in Review

Amundi sold out of Kezar Life Sciences (KZR) in Q1 2025, closing a stake of 8,224 shares — an estimated $54.1K sold.

Amundi first reported a position in KZR in Q4 2022 and held it in 7 quarters. The position peaked at $74.8K in Q4 2023. 41 funds tracked by Wall St. Rank hold KZR as of Q1 2025.

  • Amundi reported no remaining Kezar Life Sciences position as of Q1 2025 after selling out during the quarter.
  • Amundi sold 8,224 Kezar Life Sciences shares in Q1 2025, an estimated $54.1K.
  • Amundi first reported a position in Kezar Life Sciences in Q4 2022 and held it in 7 quarters.
  • Amundi's Kezar Life Sciences position peaked at $74.8K in Q4 2023.
  • 41 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2025.

Based on Amundi's 13F filing for Q1 2025, filed 15 May 2025.